KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to -$632.0 million.

  • Thermo Fisher Scientific's Cash from Financing Activities rose 46.89% to -$632.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 billion, marking a year-over-year decrease of 18.38%. This contributed to the annual value of -$6.8 billion for FY2024, which is 87.52% down from last year.
  • Thermo Fisher Scientific's Cash from Financing Activities amounted to -$632.0 million in Q3 2025, which was up 36.23% from -$991.0 million recorded in Q2 2025.
  • Thermo Fisher Scientific's 5-year Cash from Financing Activities high stood at $8.5 billion for Q4 2021, and its period low was -$4.8 billion during Q2 2021.
  • Over the past 3 years, Thermo Fisher Scientific's median Cash from Financing Activities value was -$1.2 billion (recorded in 2024), while the average stood at -$1.1 billion.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Cash from Financing Activities soared by 17,379.59% in 2021, and later tumbled by 2,406.58% in 2022.
  • Quarterly analysis of 5 years shows Thermo Fisher Scientific's Cash from Financing Activities stood at $8.5 billion in 2021, then crashed by 71.76% to $2.4 billion in 2022, then crashed by 159.72% to -$1.4 billion in 2023, then crashed by 156.72% to -$3.7 billion in 2024, then skyrocketed by 46.89% to -$632.0 million in 2025.
  • Its Cash from Financing Activities stands at -$632.0 million for Q3 2025, versus -$991.0 million for Q2 2025 and -$102.0 million for Q1 2025.